Skip to main content
. 2024 May 6;8(4):102437. doi: 10.1016/j.rpth.2024.102437

Figure 3.

Figure 3

Visualization of the discriminative ability (cumulative area under the curve [AUCt] with 95% CIs) of each risk score for major bleeding over time up to the intended timeframe, with mortality as competing event. Major bleeding was evaluated according to the International Society on Thrombosis and Haemostasis (ISTH), Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), and INTERMACS + intracranial bleeding (INTERMACS+) criteria. AF-BLEED, atrial fibrillation-BLEED; ATRIA, Anticoagulation and Risk Factors in Atrial Fibrillation; HAS-BLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly; HEMORR2HAGES, Hepatic or Renal Disease, Ethanol Abuse, Malignancy, Older Age, Reduced Platelet Count or Function, Re-Bleeding, Hypertension, Anemia, Genetic Factors, Excessive Fall Risk and Stroke; OBRI, Outpatient Bleeding Risk Index; UBRS, Utah Bleeding Risk Score; VTE-BLEED, venous thromboembolism-BLEED.